Contact
Please use this form to send email to PR contact of this press release:
MacroGenics Announces Publication of Flotetuzumab Interim Phase 1/2 Clinical Trial Results in Blood
TO:
Please use this form to send email to PR contact of this press release:
MacroGenics Announces Publication of Flotetuzumab Interim Phase 1/2 Clinical Trial Results in Blood
TO: